Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV ephedrine versus atropine versus distilled water to prevent hypotension and bradycardia after spinal anesthesia
IRCT20241102063564N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Dec 2024
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ephedrine and atropine in hypotension and bradyarrhythmia (3 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: arterial blood pressure, heart rate and 2 more. Started Dec 2024; status: completed.
02
Drugs
ephedrineatropine
03
Conditions
hypotensionbradyarrhythmia
Beyond the preview
Go deeper on IRCT20241102063564N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241102063564N1.